In the past decade, BVCF invested in nearly 30 companies, has US$400 million under management; and offered co-investment opportunities with a combined value of over US$600 million. Its investments span across China and the U.S., covering a wide spectrum of highly promising subfields including healthcare services, innovative biologics, in-vitro diagnostics (molecular diagnostics), high value medical equipments and consumables, and medical big data and mobile medicine. BVCF has a complementary team of seasoned life sciences investors with global insight and local expertise.
BVCF is managed under international fund governance rules in its investment and operations, offering sound, transparent and professional services and safe, sustainable and outsized returns. That is why BVCF has been able to attract a large number of renowned international institutional and strategic investors, and has been tremendously valuable to entrepreneurs by offering them global insights and access to the international market.